期刊
NEUROPSYCHOPHARMACOLOGY
卷 40, 期 10, 页码 2368-2378出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/npp.2015.85
关键词
-
资金
- US National Institute of Health [R37MH068542]
- National Institute of Aging [R01AG043688]
- Hope for Depression Research Foundation (HDRF)
- New York State Stem Cell Science (NYSTEM) [CO26430]
- US National Institutes of Health [1-R01MH104175]
- Ellison Medical Foundation New Scholar in Aging
- Whitehall Foundation grant
Adult hippocampal neurogenesis is increased by antidepressants, and is required for some of their behavioral effects. However, it remains unclear whether expanding the population of adult-born neurons is sufficient to affect anxiety and depression-related behavior. Here, we use an inducible transgenic mouse model in which the pro-apoptotic gene Bax is deleted from neural stem cells and their progeny in the adult brain, and thereby increases adult neurogenesis. We find no effects on baseline anxiety and depression-related behavior; however, we find that increasing adult neurogenesis is sufficient to reduce anxiety and depression-related behaviors in mice treated chronically with corticosterone (CORT), a mouse model of stress. Thus, neurogenesis differentially affects behavior under baseline conditions and in a model of chronic stress. Moreover, we find no effect of increased adult hippocampal neurogenesis on hypothalamic-pituitary-adrenal (HPA) axis regulation, either at baseline or following chronic CORT administration, suggesting that increasing adult hippocampal neurogenesis can affect anxiety and depression-related behavior through a mechanism independent of the HPA axis. The use of future techniques to specifically inhibit BAX in the hippocampus could be used to augment adult neurogenesis, and may therefore represent a novel strategy to promote antidepressant-like behavioral effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据